Background/Aims: Several studies have verified the correlation between tumor-infiltrating lymphocytes (TILs) and survival of patients with esophagus cancer (EC). However, the prognostic role of TILs is still controversial. Therefore, we performed this meta-analysis. Methods: We searched PubMed, Embase and the Cochrane Library (last update by August 30, 2017) to identify studies assessing the effect of TILs on survival of patients with EC. Pooled hazard ratios (HRs) for overall survival (OS), disease-free survival (DFS) and cancer specific survival (CSS) were estimated using fixed-effects models or random-effects models, which depends on the heterogeneity. Results: Data from 22 observational studies including 2909 patients were summarized. Pooled analysis indicated that generalized TILs were favorable prognostic markers for OS in patients with EC (pooled HR = 0.48; 95% CI = 0.38-0.61; P < 0.001). For TIL subsets, CD8
Introduction
Esophageal cancer (EC) is a kind of malignant tumor threatening human health seriously, and the morbidity in China and Japan is higher than that in Europe and America [1] . In China, the morbidity of EC is about 13/10 million, ranking first in the world [2] . Early diagnosis is vital for the treatment of EC. Besides, prognostic biomarkers with a high specificity and sensitivity are also important for appropriate therapy strategies which could improve the outcomes of patients with EC. At present, there are few biomarkers with enough specificity and sensitivity to evaluate the prognosis of patients with EC. Therefore, more studies on the prognostic biomarkers in EC is still needed.
Tumor-infiltrating lymphocytes (TILs) play an important role in tumor-associated immune responses [3] . TILs could be divided into several subsets according to the specific antigens in the cell membrane. Each of TIL subsets has different roles in the progression of tumor. CD3 is a common differentiation antigen of mature T cells, expressed on the surface of mature T cells [4] . CD4 + T cells can promote the proliferation and differentiation of immune cells, and coordinate the interaction between immune cells [5] . CD8 + T cells are the main antitumor effector cells that kill tumor cells by releasing perforin or promoting apoptosis [6] . CD57 is involved in the killing effect of activated natural killer (NK) cells and closely related to the expression of cytotoxins such as granzyme and perforin [7] . FoxP3 is a marker of regulatory T (Treg) cells which inhibit anti-tumor immune response [8] . CD45RO + T cells are known as memory T cells and have an auxiliary induction effect [9] . Therefore, the role of TILs in tumor-associated immune response is a kind of comprehensive effect regulated by the interaction of different subsets [10] .
Several studies have verified that TILs may be one of potential prognostic biomarkers for patients with EC, but the prognostic role of TILs is controversial [11] [12] [13] [14] . Zhang et al. reported that patients with high level of CD8 + TILs had better overall survival (OS) [11] , whereas Wang et al. found that patients' survival is independent of the level of CD8 + TILs [12] . Noble et al. considered high level of FoxP3 + TILs was associated with better cancer specific survival (CSS) [13] , but Vacchelli et al. suggested the opposite results [14] . In view of these controversial results, we conducted this meta-analysis to assess the prognostic role of TILs in EC.
Materials and Methods
This meta-analysis was carried out in accordance with the Systematic Reviews and Meta-Analyses (PRISMA) guidelines [15] and the Observational Studies in Epidemiology (MOOSE) guidelines [16] .
Search strategy
Literatures were searched through PubMed, Embase and the Cochrane Library (last update by August 30, 2017) . Using a range of Medical Subject Heading (MeSH) and text terms, we developed a comprehensive search strategy (S1 File). We did not impose any advanced limitations in the database searching process. Besides title, abstract and full text, all the reference lists of identified articles were also screened to further identify potential studies. The comprehensive database search and availability evaluation were carried out independently by two reviews. The disagreement from two reviews was resolved via a third reviewer.
Inclusion and exclusion criteria
Literatures that were eligible for inclusion in this meta-analysis met the following criteria: (1) studies in esophagus cancer reporting the prognostic impact of TILs or associated TILs subsets; (2) the expression of TILs or associated TILs subsets in patients with esophagus cancer; (3) sufficient data was provided to estimate the hazard ratio (HR) and 95% confidence intervals (CI); (4) only studies with sample size ≥ 30 were enrolled in this meta-analysis. The exclusion criteria were as follows: (1) studies with sample size < 30 were exclude to avoid publication bias from too small sample size, whereas if the lower limit was too large, there would be few qualified studies left; (2) case reports, letters, reviews, conference abstracts and animal
Statistical analysis
High and low expression of TILs was defined according to the cut-off values provided in the articles. The prognostic value of different level of TILs in esophagus cancer patients was evaluated by HRs and 95% CIs. An observed HR less than 1 indicated a better prognosis in patients with high expression of TILs and HR greater than 1 suggested a worse prognosis. If the statistical variables were described in the study, we extracted them directly. Otherwise, we calculated them from available numerical data in the articles according to the methods described by Tierney [18] . The data from Kaplan-Meier survival curves were obtained using Engauge Digitizer version 4.1, and the curves were read by three independent researchers to reduce reading variability. If additional information and original data were needed for the meta-analysis, we sent e-mail to the corresponding authors of eligible articles. Statistical heterogeneity was assessed by visual inspection of forest plots, by performing the Chi-square test (assessing the P value), and by calculating the I 2 statistic [19, 20] . If the P value was less than 0.05 and/or I 2 exceeded 50%, indicating the presence of heterogeneity, a random-effects model (the DerSimonian-Laird method) would be used [21] . Otherwise, the fixed-effects model (the Mante-Haenszel method) was used [22] . Subgroup analysis and meta-regression were further performed to explore the source of identified heterogeneity. Publication bias was estimated by visually assessing the asymmetry of an inverted funnel plot. Furthermore, Begg's and Egger's tests were performed to provide quantitative evidence of publication bias. If publication bias was observed, we adjusted for the effect by the use of the Duval and Tweedie trim-and-fill method [23] . For all analyses, STATA version 12.0 (Stata Corporation, College Station, TX, USA) was used with significance defined as a P-value less than 0.05 except where otherwise specified.
Results

Study characteristics
Initially, 203 articles were identified through database searching. 171 articles were excluded after preliminary screening, and then 32 articles were assessed for eligibility by reviewing the full text. Among these, 10 articles were excluded (eight without some important data and two with too small sample size). Finally, 22 studies were included in this meta-analysis ( Fig. 1) [11] [12] [13] [14] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] .
The main characteristics of all studies included in this meta-analysis are showed Fig. 1 . Flow diagram of the study selection process.
in Table 1 Table 1 .
Quality assessment
The quality of individual studies was evaluated using the NOS. The mean score of NOS for the 22 studies was 6.6, ranging from 4 to 9. A higher value indicated a better methodology. Therefore, all studies were enrolled in the subsequent analysis. [27, 29, 33, 34, 36] . Four articles evaluated patients' OS [29, 33, 34, 36] , and the pooled results showed that patients with high level of generalized TILs had better OS (pooled HR = 0.48; 95% CI = 0.38-0.61; P < 0.001) ( Table 2 ). Besides, one article evaluated patients' DFS (HR = 1.77, 95% CI = 1.17-2.69, P = 0.007) [27] , and one article evaluated patients' CSS (HR = 0.51, 95% CI = 0.35-0.75, P = 0.001) [34] . + tumor-infiltrating T lymphocytes (TILs) for patients' survival in esophagus cancer. Haz ard ratios (HR) and 95% confidence intervals (CI) from each paper are shown as horizontal black bars with grey boxes. The pooled estimation is illustrated with a blue diamond; the centre represents the pooled HR and the horizontal range indicates the 95% CI. OS, overall survival; DFS, disease-free survival; CSS, cancer specific survival.
Generalized TILs
Five articles, including 732 patients, investigated the association between generalized TILs and the survival of patients with EC
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CD8
+ T lymphocyte subset A total of 16 articles, including 2121 patients, investigated the prognostic value of CD8 + TILs in patients with EC [11-14, 24, 25, 28, 30-33, 35, 37-40] . Thirteen articles evaluated patients' OS [11, 12, 24, 28, 30-33, 35, 37-40] . The pooled results showed that patients with high level of CD8 + TILs had better OS (pooled HR = 0.68; 95% CI = 0.56-0.84; P < 0.001) (Fig.  2) , with a significant heterogeneity (I 2 = 57.5%, P = 0.005). In order to explore the sources of heterogeneity, we conducted subgroup analyses, sensitivity analysis and meta-regression. Subgroup analysis showed that high level of CD8 + TILs was associated with improved OS in groups with adenocarcinoma (pooled HR = 0.63, 95% CI = 0.45-0.89; P = 0.008), large sample size (≥100; pooled HR = 0.69, 95% CI = 0.55-0.86; P = 0.001), short follow-up time (median < 36; pooled HR = 0.60, 95% CI = 0.48-0.76; P < 0.001) and mean cut-off values (pooled HR = 0.51, 95% CI = 0.38-0.70; P < 0.001) ( Table 3) . Besides, high level of CD8 + TILs indicated a better OS in patients from Japan (pooled HR = 0.62, 95% CI = 0.48-0.82; P = 0.001), Germany (pooled HR = 0.58, 95% CI = 0.41-0.82; P = 0.002) and Switzerland (pooled HR = 0.54, 95% CI = 0.31-0.95; P = 0.033) ( Table 3 ). Sensitivity analysis was performed using the random-effects model, and the result pattern was not obviously impacted by any single study (Fig. 3A) . In addition, the results of meta-regression showed no statistically significant impact of histological type (P = 0.266), ethnicity (P = 0.308), country (P = 0.196), sample size (P = 0.908), follow-up time (P = 0.847), cut-off value (P = 0.382), publication year (P = 0.283) and analysis method (P = 0.195) on the combined effect size.
Five articles investigated the association between CD8 + TILs and patients' DFS [12, 13, 31, 38, 39] . The pooled results showed that patients with high level of CD8 + TILs had better DFS (pooled HR = 0.90; 95% CI = 0.85-0.95; P < 0.001) (Fig. 2) . In addition, three articles evaluated patients' CSS [13, 14, 25] . And the pooled results showed CD8 + TILs were not associated with patients' CSS (P = 0.268) (Fig. 2) , with a significant heterogeneity (I 2 = 54.2%, P = 0.113); Sensitivity analysis was performed using the random-effects model, and the result pattern was not obviously impacted by any single study (Fig. 3B ).
FoxP3
+ T lymphocyte subset Seven articles, including 906 tumor patients, investigated the prognostic value of FoxP3 + TILs in patients with EC [13, 14, 24, 33, 37, 39, 40] . Five articles evaluated patients' OS [24, 33, 37, 39, 40] . The pooled results showed that FoxP3 + TILs were not associated with patients' OS (pooled HR = 0.67; 95% CI = 0.44-1.03; P = 0.071) ( Table 2) , Because of the significant heterogeneity (I 2 = 70.7%, P = 0.008), sensitivity analysis was performed. And the result pattern was not obviously impacted by any single study (Fig. 3C) . 
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There were both two articles investigated the prognostic value of FoxP3+ TILs in patients' DFS and CSS _ENREF_17 [13, 14, 39] . The pooled results showed that high level of FoxP3 + TILs were associated with better DFS (pooled HR = 0.88; 95% CI = 0.81-0.96; P = 0.003), but not associated with CSS (pooled HR = 1.16; 95% CI = 0.63-2.11; P = 0.632) ( Table  2) .
CD3
+ T lymphocyte subset Five articles, including 555 tumor patients, investigated the prognostic value of CD3 + TILs in patients with EC [13, 24, 31, 33, 40] . The pooled results showed that CD3 + TILs were not associated with patients' OS, DFS and CSS (P = 0.383, P = 0.320 and P = 0.073, respectively) ( Table 2 ). Because of the significant heterogeneity among studies regarding OS (I 2 = 68.3%, P = 0.024), sensitivity analysis was performed. The result pattern was not obviously impacted by any single study (Fig. 3D) .
CD4
+ T lymphocyte subset Five articles, including 700 tumor patients, investigated the prognostic value of CD4 + TILs in patients with EC [13, 30, 37, 38, 40] . The pooled results showed that CD4 + TILs were not associated with patients' OS and DFS (P = 0.369 and P = 0.351) ( Table 2 ). However, one study indicated that high level of CD4 + TILs was associated with better CSS (HR = 0.93; 95% CI = 0.87-0.98; P = 0.011) ( Table 2) .
CD45RO
+ T lymphocyte subset Three articles, including 435 tumor patients, investigated the prognostic value of CD45RO + TILs in patients with EC [26, 31, 38] . We found that CD45RO + TILs were not associated with patients' OS (P = 0.078) and DFS (P = 0.076) ( Table 2 ). Because significant heterogeneities were found in both groups, we performed sensitivity analyses, and neither of the result patterns was obviously impacted by any single study (Fig. 3E and 3F ).
CD57
+ T lymphocyte subset Two studies, including 219 tumor patients, investigated the relationship between CD57 + TILs and patients' OS [28, 41] . The pooled result indicated that patients with high CD57 + TILs had better OS (pooled HR = 0.50; 95% CI = 0.35-0.72; P < 0.001).
Publication Bias
Because the subgroup analyzing the relationship between CD8 + TILs and patients' OS contained over 10 studies, it is necessary to evaluate the publication bias of this subgroup. Although he P values of Egger's and Begg's tests were both greater than 0.05, the funnel plot of this subgroup was not symmetric (Fig. 4) . Therefore, a publication bias may exist in this subgroup. We further used the "Trim and Fill" method to adjust for publication bias under the random-effects model. The corrected pooled multivariable-adjusted HR for OS was 0.69 (95% CI = 0.56-0.84; P < 0.001). 
Discussion
By this meta-analysis including data of a cohort of 2909 patients from 22 studies, we quantitatively estimated the prognostic value of TILs in EC. We confirmed that high level of generalized TILs was associated with better survival in patients with EC. Given that each of TIL subsets has different roles in the progression of EC, we further assessed the prognostic value of each TIL subset. The results showed that some of TIL subsets were involved in the clinical outcomes, others not.
CD8 is mainly expressed on cytotoxic T lymphocytes (CTLs) which could specifically kill tumor cells in anti-tumor immune responses [42] . Soluble tumor antigens from tumor cells are captured by antigen presenting cells (APCs), and then combined with major histocompatibility complex (MHC) class I molecules into complex which expressed on APCs. The T cell receptors (TCRs) recognize the complex and then promote the activation of CTLs which kill tumor cells by releasing perforin or promoting apoptosis [6, 43] . These previous studies were consistent with our results which showed that high level of CD8 + TILs correlated with better survival in EC in general.
FoxP3 is the specific surface marker of regulatory T cells (Tregs). Tregs can regulate the immune suppression and inability which lead to the tumor immune escape [44] . Previous studies have proved that high level of Tregs is poor prognostic role in several kinds of tumors [45, 46] . However, in our study, high level of FoxP3 + TILs were associated with better DFS, not with OS and CSS. It might be because the immunosuppression of FoxP3 + TILs is a negative feedback mechanism in which high level of FoxP3 + TILs is often accompanied with high level of CD8 + TILs [40] . CD4 is mainly expressed on helper T (Th) cells, which is a co-receptor of TCRs on Th cells. It binds to non-polypeptide region of MHC class II molecules and participates in the antigen transduction by Th cells [47] . CD4 + T cells have different subtypes which could secret various inflammations, such as IL-6, IL-17 and IL-23. IL-6 and IL-23 can activate STAT3 signaling to promote tumor growth through autocrine or paracrine modes. On the other hand, overexpression of IL-23 can enhance the anti-tumor effect of CTLs by increasing the secretion of INF-γ [5] . Besides, the effect of IL-17 secreted by CD4 + lymphocytes on tumor T cells is also bidirectional [48, 49] . Therefore, the role of CD4 + TILs may be complicated which can not only induce anti-tumor activity but also promote tumor growth, that is in agreement with the results of our study.
CD45RO is a subtype of CD45, which is an important marker of memory T cells. There are several subgroups of memory T cells, each with a different role in the development of tumors. CD45RO + T cells are capable of immune surveillance which exhibit a strong and effective antitumor immune response after re-stimulation of tumor-associated antigens [50] . However, Viguiter et al. reported that CD45RO + T cells overexpressed some immunosuppressive cytokines, such as IL-10 and TGF-b, which can effectively inhibit the function of the CTLs, and that is an important reason for tumor metastasis [51] . In our study, CD45RO + TILs were not associated with patients' survival.
CD3 is a general surface antigen of T cells and combined with TCR by a noncovalent bond [4] . Therefore, the CD3 + TILs may represent the whole tumor infiltrating T cells. Because of the complex functions of various T cells, CD3 + TILs may not correlate to patients' survival that is also consistent with our results. In addition, CD57
+ NK cells could kill the tumor cells by releasing granzyme and perforin [7] . NK cells-mediated cytotoxicity is independent of MHC class I molecules expressed on tumor cells. Smyth et al. found that NK cells-mediated cytotoxicity was involved in the clearance of MHC class I-deficient tumor cells and could prevent tumor metastasis [52] . Our result showed that high level of CD57 + TILs correlated with better survival in EC.
The [55] . In contrast, our study found that CD4 + had no prognostic value and high level of FOXP3 + TILs was associated with better DFS. The major reason for the differences may due to the pathological difference. Besides, insufficient sample size may also affect the reliability of results. Although previous studies have proved the prognostic role of TILs, this meta-analysis is the first study to evaluate the prognostic value of TILs in EC. Of cause, there are still some deficiencies in our study. First, the cut-off values were different that would affect the availability of TILs as a prognostic biomarker in cancer. Second, several HRs were calculated based on the data extracted from Kaplan-Meier survival curves that inevitably led to statistical errors. Third, univariate analyses were used in some studies that would overestimate the effect sizes. Finally, the studies of CD3 + , CD4
+ and CD45RO + TILs were really few, which resulted in the impossibility of subgroup analyses.
In addition to being a prognostic biomarker for tumor patients, TILs could also serve as a target for immunotherapy. Immunotherapy, which is more tumor-specific and less toxic, has become a new anti-tumor treatment [56] . Augmentation of the local anti-tumor immune response is the main mechanism of immunotherapy [57] . New immunotherapy drugs pembrolizumab and nivolumab, which could effectively enhance the anti-tumor effects of CD8 + TILs, have been applied in clinic with significant curative effect for various types of advanced tumors including EC [58, 59] . Our study indicated that CD8 + , CD57 + , and FoxP3 + TILs were all associated with patients' survival in EC. Based on these, we hypothesized that CD57 + and FoxP3 + TILs might be potential targets for immunotherapy like CD8 + TILs.
Conclusion
In conclusion, this meta-analysis proved that TILs might serve as a prognostic biomarker for patients with EC. More experiments and clinical trials with large sample size are required to further confirm the prognostic significance of TILs in EC.
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